These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 22430887)

  • 21. Update on Anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study.
    Desplat-Jégo S; Johanet C; Escande A; Goetz J; Fabien N; Olsson N; Ballot E; Sarles J; Baudon JJ; Grimaud JC; Veyrac M; Chamouard P; Humbel RL
    World J Gastroenterol; 2007 Apr; 13(16):2312-8. PubMed ID: 17511029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn's disease.
    Canani RB; Romano MT; Greco L; Terrin G; Sferlazzas C; Barabino A; Fontana M; Roggero P; Guariso G; De Angelis G; Fecarotta S; Polito G; Cucchiara S
    Inflamm Bowel Dis; 2004 May; 10(3):234-9. PubMed ID: 15290917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis.
    Lu H; Lian L; Navaneethan U; Shen B
    Inflamm Bowel Dis; 2010 Oct; 16(10):1678-84. PubMed ID: 20186934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn's disease in Asians.
    Ng SC; Hirai HW; Tsoi KK; Wong SH; Chan FK; Sung JJ; Wu JC
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1664-70. PubMed ID: 24910240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Saccharomyces cerevisiae antibody titers are stable over time in Crohn's patients and are not inducible in murine models of colitis.
    Müller S; Styner M; Seibold-Schmid B; Flogerzi B; Mähler M; Konrad A; Seibold F
    World J Gastroenterol; 2005 Nov; 11(44):6988-94. PubMed ID: 16437604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis.
    Kim YS; Kim YH; Kim WH; Kim JS; Park YS; Yang SK; Ye BD; Jang BI; Jung SA; Jeen YT; Cheon JH; Choi YS; Choi JH; Kim BJ; Choi CH; Han DS
    Clin Chim Acta; 2011 Aug; 412(17-18):1527-32. PubMed ID: 21575618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Saccharomyces cerevisiae antibodies in Japanese patients with inflammatory bowel disease: diagnostic accuracy and clinical value.
    Hisabe T; Matsui T; Sakurai T; Murakami Y; Tanabe H; Matake H; Yao T; Kamachi S; Iwashita A
    J Gastroenterol; 2003; 38(2):121-6. PubMed ID: 12640524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anti-Saccharomyces cerevisiae antibody assay in a province-wide practice: accurate in identifying cases of Crohn's disease and predicting inflammatory disease.
    Kaila B; Orr K; Bernstein CN
    Can J Gastroenterol; 2005 Dec; 19(12):717-21. PubMed ID: 16341311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis.
    Torres J; Petralia F; Sato T; Wang P; Telesco SE; Choung RS; Strauss R; Li XJ; Laird RM; Gutierrez RL; Porter CK; Plevy S; Princen F; Murray JA; Riddle MS; Colombel JF
    Gastroenterology; 2020 Jul; 159(1):96-104. PubMed ID: 32165208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.
    Coukos JA; Howard LA; Weinberg JM; Becker JM; Stucchi AF; Farraye FA
    Dig Dis Sci; 2012 Jun; 57(6):1544-53. PubMed ID: 22311367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.
    Müller S; Schaffer T; Schoepfer AM; Hilty A; Bodmer T; Seibold F
    World J Gastroenterol; 2008 Jun; 14(23):3650-61. PubMed ID: 18595132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease].
    Le Goff C; Chapelle JP; Lutteri L
    Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibody in Iranian patients with inflammatory bowel disease.
    Bahari A; Aarabi M; Aarabi M; Hedayati M; Jarollahi A; Firouzi F; Aghazadeh R; Zali MR; Hashemi M
    Acta Gastroenterol Belg; 2009; 72(3):301-5. PubMed ID: 19902862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.
    Gologan S; Iacob R; Preda C; Vadan R; Cotruta B; Catuneanu AM; Iacob S; Constantinescu I; Gheorghe L; Iobagiu S; Gheorghe C; Diculescu M
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):39-44. PubMed ID: 22457858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic role and clinical association of ASCA and ANCA in Brazilian patients with inflammatory bowel disease.
    Nisihara RM; de Carvalho WB; Utiyama SR; Amarante H; Baptista ML
    Dig Dis Sci; 2010 Aug; 55(8):2309-15. PubMed ID: 19826949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
    Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
    Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role.
    Biet F; Gendt L; Anton E; Ballot E; Hugot JP; Johanet C
    Dig Dis Sci; 2011 Jun; 56(6):1794-800. PubMed ID: 21221802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.
    Walker LJ; Aldhous MC; Drummond HE; Smith BR; Nimmo ER; Arnott ID; Satsangi J
    Clin Exp Immunol; 2004 Mar; 135(3):490-6. PubMed ID: 15008984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease.
    Israeli E; Grotto I; Gilburd B; Balicer RD; Goldin E; Wiik A; Shoenfeld Y
    Gut; 2005 Sep; 54(9):1232-6. PubMed ID: 16099791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.